
Veeva Systems (VEEV) Stock Forecast & Price Target
Veeva Systems (VEEV) Analyst Ratings
Bulls say
Veeva Systems is well-positioned for continued growth and margin stability due to its dominant position in the life sciences industry and focus on providing best-of-breed solutions. Despite recent noise from competitors, Veeva's top 20 CRM customers are expected to remain with the company and there is potential for customers to return from highly customized Salesforce solutions due to cost and complexity. With a strong balance sheet and initiatives in AI, we believe Veeva has the potential for continued success and we have a Buy rating on the stock.
Bears say
Veeva Systems is currently the dominant front-office vendor in the life sciences industry and has recently extended its market position into drug development, indicating a positive outlook for the company. With a growing total addressable market (TAM) and focused, industry-specific products, Veeva is expected to continue as a mid-teens grower for years to come. However, investors should be cautious of potential risks, such as a decline in the growth rate of Veeva Vault or lack of adoption for new CRM add-ons. Despite a high valuation compared to its peers, Veeva's stability and strategic positioning make it a strong buy.
This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.
Veeva Systems (VEEV) Analyst Forecast & Price Prediction
Start investing in Veeva Systems (VEEV)
Order type
Buy in
Order amount
Est. shares
0 shares